ERNA-101 and ERNA-102 have the potential to bring significant hope in the treatments of ovarian cancer and autoimmune disease, respectively. Ernexa’s ticker symbol will remain as ERNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback